Foundation tier · Injury & Tissue Repair
BPC-157 for Injury & Tissue Repair
A synthetic pentadecapeptide showing promise in tissue repair and gut healing research.
Medical Disclaimer
Why BPC-157 for Injury & Tissue Repair
Role in Protocol
Tissue repair and anti-inflammatory support
Evidence Note
A synthetic pentadecapeptide with extensive preclinical data showing accelerated healing in tendons, ligaments, muscles, and the GI tract. Mechanisms include angiogenesis promotion and growth factor modulation. Awaiting human RCTs.
Literature Dosing
250-500 mcg SC daily -- based on preclinical dosing extrapolation
Dosing Context
Tissue Repair (Clinic Protocol)
Dose
200–500 mcg
Frequency
daily
Duration
4-8 weeks, then 2-4 weeks off
GI Healing (Oral)
Dose
250–500 mcg
Frequency
daily
Key Safety Notes
Active cancer
BPC-157 promotes angiogenesis — theoretical concern for tumour vascularisation.
Full BPC-157 Profile →
Full Injury & Tissue Repair Protocol →